FindTrial
Sign In

To determine Visual Improvement in Conical Protrusion of eye by inserting Lens into the eye as a treatment

Outcomes of Posterior Chamber Phakic IOL in stable keratoconus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044988
Enrollment
25
Registered
2022-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H186- Keratoconus

Interventions

Intervention1: Posterior Chamber Phakic IOL: Posterior Chamber Phakic IOL Intervention2: posterior chamber phakic IOL: In this study, we want to compare UCDVA, BCDVA, Manifest Refraction and Endotheli
therefore, it is a

Sponsors

Sankara Eye Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.21 years above 2. stable refraction for 1 year after CXL 3.Less than stage 2 keratoconus 4. contact lens intolerant 5.clear central cornea 6.pupil size 7.angle width >30 degree

Exclusion criteria

Exclusion criteria: 1.progressive keratoconus 2.endothelial cell count 3. other eye disease : cataract , glaucoma, retinal detachment,retinopathy

Design outcomes

Primary

MeasureTime frame
Manifest Refraction UCDVA, BCDVATimepoint: UCDVA, BCDVA on Day 1—

Secondary

MeasureTime frame
Endothelial Cell Count IOP AC depthTimepoint: 1 Day, 1 Week, 1 Month, 6 Months—

Countries

India

Contacts

Public ContactDrMasbooba MP

Sankara Eye Hospital

jkreddy@sankaraeye.com8838340385

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026